3:09 PM
 | 
Apr 12, 2018
 |  BC Extra  |  Company News

Management tracks: Verona, Medigene, NeoPhore

Respiratory disease company Verona Pharma plc (LSE:VRP; NASDAQ:VRNA) said CMO Kenneth Newman will resign, effective April 30. The company is seeking a successor.

Cancer immunotherapy company Medigene AG (Xetra:MDG1) said CMO and SVP Kai Pinkernell will transition to CMO and chief development officer.

Cancer immuno-oncology company NeoPhore Ltd. (Cambridge, U.K.) hired Jeffrey Roix as CEO. He was COO at PhoreMost Ltd. (Cambridge, U.K.).

Cancer epigenetics company NeoMed Therapeutics 1 Inc. (Montreal, Quebec) hired Francis Giles as CMO. He was director of developmental therapeutics at the Robert H. Lurie Comprehensive Center at Northwestern University (Evanston, Ill.) and chief of hematology and oncology at the Northwestern University Feinberg School of Medicine (Chicago, Ill.).

Neurology company BioAxone BioSciences Inc. (Cambridge, Mass.) hired Ronald Goldstein as CFO. He was CFO at Cyteir Therapeutics Inc. (Cambridge, Mass.).

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD